Metabolic syndrome

Abstract

Metabolic syndrome (MetS) is a metabolic dysfunction that directly increases the risk of cardiovascular disease and type 2 diabetes mellitus, primarily associated with insulin resistance and visceral adiposity. In addition to developed and developing countries, its prevalence has increased in low-income countries and has become a global problem today. In addition to pathologies used in diagnoses such as atherogenic dyslipidemia, impaired fasting glucose, increased waist circumference, elevated triglyceride, and hypertension, it also appears as a prothrombotic and proinflammatory process as a result of cytokines and hormones secreted from adipose tissue. The most effective and first choice in treatment is a lifestyle change. Pharmacological treatment should be considered in people whose risk factors cannot be adequately reduced by lifestyle changes.